WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced availability of a newly created “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”
“This guidance seeks to help AdvaMed members and other medical technology companies develop and implement processes that both support rapid decision-making in the context of the pandemic and mitigate any related compliance risks,” said Christopher L. White, AdvaMed COVID action team leader, chief operating officer and general counsel.
“As medtech companies supporting the public health response to COVID-19 work around the clock to produce essential medical products to help prevent, detect and treat this disease, we must continue to do all we can to help ensure patients are provided both timely and ethical access to our equipment, knowledge and trained personnel,” White said.
Development of the guidance was overseen by AdvaMed’s Global Compliance Steering Committee, with active input from over a dozen member company compliance officers.
“The guidance complements AdvaMed’s existing Code of Ethics, and addresses shared compliance concerns, experiences and best practices developed by our member companies as they respond to the COVID 19 pandemic. Key topics addressed in the guidance include ongoing contractual/legal obligations during a declared state of emergency; charitable donations including products, equipment, services, and/or financial support; volunteer activity by company personnel; virtual educational events; and other company processes,” White said.
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.